Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-733

Known as: MK 733, MK733 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
SummarySimvastatin (MK733), derived from lovastatin by substituting CH3 for H at the 2′ position, is a potent… Expand
  • table I
  • figure 2
  • figure 1
  • table II
  • figure 3
Is this relevant?
1992
1992
The effect of simvastatin (MK-733), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on the… Expand
Is this relevant?
1991
1991
The effect of simvastatin (MK-733), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on plasma… Expand
Is this relevant?
Review
1989
Review
1989
The efficacy of simvastatin, a new inhibitor of cholesterol biosynthesis, was studied in patients with familial… Expand
Is this relevant?
1989
1989
MK-733 (simvastatin), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, was found to inhibit the… Expand
Is this relevant?
1989
1989
MK-733 was found to prevent an increase of serum cholesterol levels in cholesterol-fed rabbits, and lovastatin also markedly… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The power of serum lathosterol concentration as an indicator of whole-body cholesterol synthesis was investigated in 47 human… Expand
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
1988
1988
Simvastatin (MK-733), a new inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, was administered to 38 patients with… Expand
Is this relevant?
1988
1988
Effects of MK-733 on the absorption and excretion of cholesterol in rabbits were examined using [3H]cholesterol. The animals were… Expand
Is this relevant?
1986
1986
The effects of synvinolin (MK-733), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, were investigated… Expand
Is this relevant?